Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 6,440 | 29,621 | 46,803 | 140,734 | 235,309 |
| Cost of Goods | 556 | 15,561 | 3,962 | 20,280 | 12,871 |
| Gross Profit | 5,884 | 14,060 | 42,841 | 120,454 | 222,438 |
| Operating Expenses | 52,335 | 165,037 | 366,524 | 421,759 | 511,839 |
| Operating Income | -45,895 | -150,416 | -322,721 | -301,025 | -288,530 |
| Interest Expense | 8,759 | 8,247 | 8,095 | 1,440 | 1,075 |
| Other Income | -3,640 | 5,296 | 7,594 | 7,596 | -1,078 |
| Pre-tax Income | -58,294 | -153,367 | -323,222 | -294,869 | -290,683 |
| Income Tax | -90 | -269 | -252 | 358 | 347 |
| Net Income Continuous | -58,204 | -153,098 | -322,970 | -293,654 | -290,023 |
| Net Income Discontinuous | 241,656 | 105,519 | 38,738 | N/A | N/A |
| Net Income | $183,452 | $-47,579 | $-284,232 | $-293,654 | $-290,023 |
| EPS Basic Total Ops | 45.37 | -11.89 | -73.00 | -78.50 | -78.50 |
| EPS Basic Continuous Ops | -14.40 | -38.26 | -83.00 | -78.45 | -78.51 |
| EPS Basic Discontinuous Ops | 59.77 | 26.37 | 10.00 | N/A | N/A |
| EPS Diluted Total Ops | 45.37 | -11.89 | -73.00 | -78.50 | -78.50 |
| EPS Diluted Continuous Ops | -14.40 | -38.26 | -83.00 | -78.45 | -78.51 |
| EPS Diluted Discontinuous Ops | 59.77 | 26.37 | 10.00 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -38.25 | -63.50 | -78.50 | -78.50 |
| EBITDA(a) | $-45,219 | $-149,404 | $-317,852 | $-288,802 | $-271,239 |